ArticleJournal of surgical oncology2026
Does Surgical Timing After Neoadjuvant Anti-HER2 Therapy Affect Pathological Complete Response and Survival in HER2-Positive Breast Cancer? A Multicenter Retrospective Cohort Study.
Zeliha Birsin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.